JR8603 / JiaRay Group - LARVOL DELTA

A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=94 | Recruiting | Sponsor: JiaRay Group | N=65 ➔ 94

Enrollment change • Colorectal Cancer • Esophageal Cancer • Gastric Cancer • Oncology • Solid Tumor

A First-in-Human, Open-Label, Dose Escalation and Expansion Study of JR8603 in Patients with Advanced Solid Tumors (ChiCTR) - P1 | N=94 | Recruiting | Sponsor: Harbin Medical University Cancer Hospital; Harbin Medical University Cancer Hospital | -> Recruiting

Enrollment open • Solid Tumor

A First-in-Human Escalation and Expansion Study of Patients with Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=65 | Recruiting | Sponsor: JiaRay Group

New P1 trial • Colorectal Cancer • Esophageal Cancer • Gastric Cancer • Oncology • Solid Tumor